quest biotechnology inc said its quest blood substitute inc subsidiary executed agreement with alza corp which will alza preferred shareholder its subsidiary quest said agreement also offers alza right acquire pct unit equity exchange for acquisition patent rights alza technology area quest has interest quest also said its signed merger agreement with and its affiliate quest said expects complete merger within next several weeks reuter 